Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride vs furosemide for edema in nephrotic syndrome
2019-002607-18Phase 3Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amiloride in nephrosis (2 arms), sponsored by University Hospital Tübingen. Started Nov 2019; status: terminated.
02
Drugs
amiloride
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2019-002607-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002607-18.